Title:
化合物又はその塩、抗炎症剤、肺がんに対する抗がん剤、化合物又はその塩の製造方法、炎症性疾患の治療方法及び肺がんの治療方法
Document Type and Number:
Japanese Patent JP6656677
Kind Code:
B2
Abstract:
The present invention provides a new compound having excellent safety which can be used as an anti-inflammatory agent, an anti-cancer agent against lung cancer, and the like. The compound or the salt thereof of the present invention is a compound represented by Formula (A) or Formula (B):where:Xis a hexose or a hydroxyl group, andXis a phosphate group or a hydroxyl group.
Inventors:
Toshihiro Toda
Yasuhiro Hidaka
Hayashi Akira
Takashi Nishizawa
Shinichiro Nakamura
Osamu Kanie
Yoshiki Yamaguchi
Yasuhiro Hidaka
Hayashi Akira
Takashi Nishizawa
Shinichiro Nakamura
Osamu Kanie
Yoshiki Yamaguchi
Application Number:
JP2018541005A
Publication Date:
March 04, 2020
Filing Date:
September 13, 2017
Export Citation:
Assignee:
TFK Corporation
International Classes:
C12P19/04; A61K31/726; A61P11/00; A61P29/00; A61P35/00
Domestic Patent References:
| JP2008537749A | ||||
| JP2200635A |
Foreign References:
| WO2011102035A1 | ||||
| WO2000042994A2 | ||||
| WO2007011055A1 |
Other References:
PERERA, P.-Y. et al.,Infection and Immunity,1998年,Vol.66, No.6,p.2562-2569
Attorney, Agent or Firm:
Koichiro Tsujimaru
Yumi Nakayama
Isaji So
Yumi Nakayama
Isaji So